Back to Journals » Drug Design, Development and Therapy » Volume 12

Original Research

HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

       
Total article views   HTML views PDF downloads Totals
15,768 Dovepress* 14,685+ 1,053 15,738
PubMed Central* 1,083 280 1,363
Totals 15,768 1,333 17,101
*Since 23 July 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 1 0 0 1 2

View citations on PubMed Central and Google Scholar